Dyspepsia/Indigestion Flashcards
what is achalasia?
An oesophageal motor disorder. Loss of oesophageal peristalsis and failure of lower oesophageal sphincter to relax
what are the presenting symptoms of achalasia?
dysphagia to solids and liquids, regurgitation and retrosternal pain which is slowly progressive over months or years. Patients may alter posture to enable swallowing.
what are oesophageal strictures?
- Abnormal narrowing of the oesophageal lumen, often presents as dysphagia.
- It can be due to inflammation, fibrosis or neoplasia.
- The oesophagus loses distensibility and the stricture may be localised or diffuse.
what are the types of oesophageal strictures?
benign or malignant
most are a result of benign peptic strictures from GORD (risk reduced with PPIs). There is damage to the mucosal lining which over time leads to chronic inflammatory changes.
Malignant strictures develop from intrinsic direct proliferation and invasion of cancer cells from luminal mucosa.
what is the aetiology of benign strictures?
- Corrosive substance ingestion
- Eosinophilic oesophagitis
- Drug induced oesophagitis
- Radiation injury
- Iatrogenic stricture post-endoscopic therapy
- Anastomotic stricture
- Chemotherapy induced oesophageal stricture
- Thermal injury
- Infectious oesophagitis
- Other causes: (prolonged use of nasogastric tube, collagen vascular diseases such as scleroderma, benign mucosal pemphigoid, graft versus host disease, oesophageal web in plummer-vinson syndrome, Crohn disease, tuberculosis)
what is the aetiology of malignant strictures?
- Oesophageal adenocarcinoma
- Oesophageal squamous cell carcinoma
- Metastatic oesophageal neoplasm (usually lung cancer)
what are the important things to ask for in a patient with strictures?
- Dysphagia (progressive dysphagia)
- Food impaction
- Odynophagia
- Chest pain
- Weight loss
- Rate and type of symptom progression correlates with underlying type of stricture
- Physical examination not significant
- Malignant stricture (Develop rapidly)
- Benign stricture (Slow and insidious course)
- history of GORD, barrets, hiatus hernia, medication
- prior endoscopic treatment or oesophageal surgery
- radiation therapy
- meds (alendronate, tetracycline, antibiotics, NSAIDs)
what is the clinical presentation of peptic ulcer disease?
Usually present as chronic, upper abdominal pain related to eating a meal.
Due to NSAIDs and H.pylori
May be epigastric tenderness
what is the clinical presentation of GORD?
Risk factors such as family history of heartburn or GORD, obesity, older age, hiatus hernia.
Heartburn-burning sensation in chest after meals, worse when lying down, can occur at night but not usually exertional.
Reflux of acid into mouth with sour taste after meals
what is the clinical presentation of functional dyspepsia?
Sensation in upper gut and pain. Heartburn, sour taste in mouth, excessive burping, nausea and vomiting
what are the investigations for peptic ulcer disease?
H. Pylori urea breath test or stool antigen test. (patients <60)
Upper GI endoscopy-most specific and sensitive (patients over 60 or over 55 if weight loss). Endoscopy repeated 6-8 weeks later in patients with gastric ulcer to ensure healing
FBC-only if patient looks clinically anaemic or evidence of GI bleeding
what are the investigations for GORD?
PPI trial-further tests if no symptom relief after 8 weeks
OGD-with alarm symptoms
Ambulatory pH monitoring-can demonstrate abnormal exposure to oesophageal acid
Oesophageal manometry-evaluate oesophageal contractions and lower sphincter function
Combined impedance pH testing-quantify exposure to acid
Barium swallow-may be complementary to endoscopy for dysphagia
Oesophageal capsule endoscopy-visualise oesophagus without sedation
what are the investigations for functional dyspepsia?
No definitive diagnostic test. Cannot confirm dysmotility with any test. Normal X-ray or gastroscopy doesn’t mean there is nothing wrong
what are the investigations for H.pylori?
Blood test
Breath test-swallow pill containing tagged carbon molecules. With H.pylori carbon is released when solution is broken down
Stool test-stool antigen test
Scope test-upper endoscopy exam, biopsy which is analysed for H.pylori
what is the management for an active bleeding peptic ulcer?
mostly treated endoscopically, PPI reduce rebleeding. Stop NSAIDs, blood transfusion if needed, assess for H.pylori.
what is the management for a none active bleeding peptic ulcer?
eliminate underlying cause, ulcer healing therapy. Assess for H.pylori
H.Pylori negative-stop NSAIDs, ulcer healing therapy (PPIs), sucralfate, misoprostol
H.Pylori positive-eradication therapy
what is the management for mild typical GORD?
antacids, H2 antagonists, lifestyle changes. PPIs plus lifestyle changes are first line. Start with lowest effective dose of PPI. bedtime adjunctive H2 antagonists for people with nocturnal symptoms
what is the management for atypical/complicated GORD?
immediate endoscopy and also treated with PPIs
what is the management for functional dyspepsia
Treat for H.pylori if present. Low doses of antidepressants might reduce syptoms, PPIs
what treatment is used if a patient tests positive for H.pylori?
Eradication therapy should be started. Stop NSAIDs. This causes ulcer healing and a dramatic decrease in ulcer recurrence.. Therapy shouldn’t be started without infection. Triple therapy (a PPI plus two antibiotics) is recommended first-line in select patients.
describe H.pylori triple therapy?
Clarithromycin-based triple therapy (a PPI plus clarithromycin plus either amoxicillin or metronidazole) is a first-line treatment option in regions where clarithromycin resistance is known to be low (<15%) and in patients who have no previous history of macrolide antibiotic exposure. In patients who are allergic to penicillin, metronidazole should replace amoxicillin.
what is quadruple therapy for H.pylori?
Quadruple therapy (a PPI plus bismuth plus tetracycline plus a nitroimidazole such as metronidazole or tinidazole) is recommended for patients with previous macrolide exposure. Quadruple therapy is also an option for patients with penicillin allergy.
what are bismuth based regimens and sequential therapy for H.pylori eradication?
Bismuth-based regimens and sequential therapy (i.e., 5 days PPI plus amoxicillin, followed by 5 days PPI plus clarithromycin and a nitroimidazole) may have comparable eradication rates to standard triple first-line therapy.
H.pylori eradication
- concominant therapy
- hybrid therapy
- levofloxacin triple therapy
- fluoroquinolone sequential therapy
- Concomitant therapy (PPI, clarithromycin, amoxicillin, and a nitroimidazole)
- hybrid therapy (PPI and amoxicillin for 7 days, followed by a PPI, amoxicillin, clarithromycin, and a nitroimidazole for 7 days),
- levofloxacin triple therapy (PPI, levofloxacin, and amoxicillin),
- fluoroquinolone sequential therapy (PPI and amoxicillin for 5-7 days followed by a PPI, fluoroquinolone, and nitroimidazole for 5-7 days)
alternative first-line treatment strategies.
what are the principles of all types of H.pylori eradication?
All regimens contain antibiotics and therefore may cause diarrhoea, promote opportunistic infections, and interfere with absorption of many other drugs, including oral contraceptives.
Check for eradication of H pylori 1 month after the end of therapy. Continuation of acid suppressive therapy after treatment of infection is not necessary in most patients.
If the first treatment fails, at least one alternative regimen should be tried. Second-line regimens should avoid the antibiotics that were given in the first-line regimen. If the organism cannot be eradicated despite repeated attempts, long-term acid suppression therapy may be necessary to control symptoms.
In areas with high rates of multiple drug resistance, pre-treatment antimicrobial susceptibility-guided therapy may be more effective than clarithromycin-based triple therapy alone for H pylori eradication. However, H pylori culture and molecular testing is not widely available in all countries.
Gastric Cancer
- symptoms
- investigations
- treatments
- complications
- weight loss, abdominal pain. If proximal or gastro-oesophageal junction tumour can be dysphagia. Mainly adenocarcinomas but can also be lymphoma, leoimyosarcoma, neuroendocrne tuours, squamous cell carcinomas
- OGD with biopsy and staging based on imaging
- Early stage disease is treated with surgery alone. Locally advanced disease is treated with multimodality approach including surgery and postoperative chemoradiation. Metastatic disease is treated with chemotherapy, immunotherapy, chemoradiation.
- Complications include gastric bleeding and gastric outlet obstruction.
what is the epidemiology of gastric cancer?
Twice as likely in men than women and more common with older people. In recent years the incidence has decreased but tumours from cardia are increasing. More common in japan, china, finland and columbia than west.
what is the aetiology of gastric cancer?
Associated with consumption of smoked and salted foods and lack of refrigeration. Association with H.pylori, blood group A, gastric adenomatous polyps, pernicious anaemia, smoking.
describe the pathophysiology of gastric cancer?
loss of tumour supression gene p53. proto-oncogenes such as ras, c-myc, erbB2 (HER2/neu) overexpressed
There are 4 main genomic subtypes:
- Tumours positive for epstein barr
- Microsatellite unstable tumours
- Genomically stable tumours
- Chromosomal unstable tumours